EP Patent

EP0437694B1 — Verwendung einer Hydroxyoctadecadiensäure, deren zur Ketoform oxidierte Säure sowie deren Derivate zur Therapie östrogenabhängiger Krankheiten, sowie pharmazeutische Zusammensetzungen, die diese enthalten

Assigned to BOOTS PHARMA GMBH · Expires 1993-06-16 · 33y expired

What this patent protects

Patent listed against birch-triterpenes.

Drugs covered by this patent

Patent Metadata

Patent number
EP0437694B1
Jurisdiction
EP
Classification
—
Expires
1993-06-16
Drug substance claim
No
Drug product claim
No
Assignee
BOOTS PHARMA GMBH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.